Senior insider sale
See Remarks at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$3.51M
283.33K shares
KIRN DAVID plans to sell 283.33K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $3.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
Acquired from issuer in private transaction
None
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/6/2025 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 50K | — |
12/15/2020 | Acquired from issuer in private transaction None | 19.08K | — |
| Total | 69.08K | ||
Completed
Units to sell
26.84K
Market value
$274.6K
Units to sell
12.41K
Market value
$124.7K
Units to sell
15.72K
Market value
$189.2K
Units to sell
42.61K
Market value
$548.2K
Units to sell
114.75K
Market value
$1.20M
Units to sell
1.92K
Market value
$19.3K
Planned — Approximate Date
Units to sell
69.08K
Market value
$1.16M
Units
283.33K
Value
$3.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/4/2026 | 26.84K | $274.6K | — | Completed |
8/3/2026 | 12.41K | $124.7K | — | Completed |
7/10/2026 | 15.72K | $189.2K | — | Completed |
7/9/2026 | 42.61K | $548.2K | — | Completed |
6/22/2026 | 114.75K | $1.20M | — | Completed |
6/1/2026 | 1.92K | $19.3K | — | Completed |
| Planned — Approximate Date | ||||
8/19/2026 | 69.08K | $1.16M | NASD | Planned |
| Total | 283.33K | $3.51M | ||